Effect of amino acid cardioplegia on myocardial metabolism and function of ischemic canine heart.
To evaluate the effect of amino acid cardioplegia on myocardial metabolism and function of ischemic canine heart, canine cardiopulmonary bypass (CPB) model was established and the dog heart was subjected to a 120 min ischemic arrest. Animals were divided into 3 groups, group 1: warm blood cardioplegia induction and terminal perfusion plus 4 C ST. Thomas hospital solution (STS) during ischemia; group 2: warm blood cardioplegia enriched with amino acid (L-asparte and L-glutamate 13 mmol/L each) and STS without amino acid (A. G.) and group 3: both warm blood cardioplegic solution and STS enriched with A. G. . The result demonstrated that the cardiac function of animals in group 2 and 3 had a significantly better recovery after ischemic-re-perfusion. By the end of ischemia the content of myocardial ATP in group 3 was distinctly higher than that in group 1 (P < 0.05), with the release of cardiac enzyme being the least. Myocardial ultra-structure almost remained intact before and after ischemia. Our experiment suggests that the cardioplegia arrest with warm blood and cold crystalloid solution enriched with amino acids could diminish the ischemia-re-perfusion injuries of the heart and enhance the effect of myocardial protection.
Zhang
K
K
Institute of Cardiovascular Diseases, Tongji Medical University, Wuhan.
Lan
H
H
Cheng
G
G
Fu
P
P
Huang
Y
Y
Xu
Z
Z
Feng
H
H
D000596:Amino Acids; D000818:Animals; D001224:Aspartic Acid; D001769:Blood; D002314:Cardioplegic Solutions; D004285:Dogs; D018698:Glutamic Acid; D006324:Heart Arrest, Induced; D006358:Hot Temperature; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control*; D009206:Myocardium / Q000378:metabolism*
D000596:Amino Acids; D002314:Cardioplegic Solutions; D001224:Aspartic Acid; D018698:Glutamic Acid